Understanding COPD Etiology, Pathophysiology, and Definition.

Area of Science:

• Pulmonary Medicine
• Genetics
• Immunology

Background:

• Chronic obstructive pulmonary disease (COPD) is a major global health issue with limited disease-modifying therapies.
• Patient heterogeneity in COPD phenotypes complicates the development of effective treatments.
• Current understanding suggests complex gene-environment interactions and multiple inhalational exposures contribute to COPD development.

Purpose of the Study:

• To review the current understanding of COPD etiology and pathophysiology.
• To discuss progress in identifying specific pathological processes leading to COPD phenotypes, especially small airways disease.
• To provide background on the calls for expanding COPD diagnostic criteria and associated challenges.

Main Methods:

• Literature review of recent advances in COPD research.
• Analysis of imaging techniques correlating with histological damage.
• Examination of immunological mechanisms in COPD pathogenesis.

Main Results:

• Significant progress has been made in understanding discrete COPD phenotypes, particularly small airways disease.
• Advances in imaging and immunology offer potential for personalized COPD therapies.
• Growing recognition that current spirometry-based diagnostic criteria may exclude individuals with similar disease manifestations.

Conclusions:

• Understanding COPD heterogeneity is crucial for developing novel, disease-modifying therapies.
• Personalized treatment strategies are emerging based on specific pathological and immunological insights.
• Expanding diagnostic criteria for COPD is being increasingly advocated, despite implementation challenges.